Plasma vs Tissue Genotyping: Debate is organized by Society for Translational Oncology (STO).
Released: 05/05/2021
Expires: 05/04/2022
Target Audience
Physicians who wish to advance their current knowledge of the advantages and limitations of using tumor tissue as a sample source for genotyping.
Learning Objectives:
• Understand the key nuances of genomic reports.
• Effectively integrate cell-free DNA profiling and clinical decision-making.
• Identify genomic markers of response and resistance.
• Understand the advantages and limitation of using tumor tissue as a sample source for genotyping.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved